Amedisys (AMED)
(Delayed Data from NSDQ)
$96.12 USD
+0.08 (0.08%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $96.15 +0.03 (0.03%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.12 USD
+0.08 (0.08%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $96.15 +0.03 (0.03%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth C Momentum A VGM
Zacks News
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
4 Healthcare Stocks That Popped More Than 100% in 2018
by Sapna Bagaria
Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.
4 Medical Device Stocks That More Than Doubled in 2018
by Sweta Jaiswal
Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.
Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock
by Zacks Equity Research
Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock
5 Stocks With Recent Price Strength to Enhance Your Return
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Sweta Killa
Sector ETF report for PSCH
5 Stocks That Popped More Than 100% in 2018 Defying All Odds
by Sreyoshi Mukherjee
Five solid picks that defied the problems confronting the U.S. economy.
Has Amedisys (AMED) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Amedisys, Colgate-Palmolive, Deutsche, Societe General and Danske highlighted as Zacks Bull and Bear of the Day
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
by Zacks Equity Research
Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems
Bull of the Day: Amedisys (AMED)
by Madeleine Johnson
After blowout earnings, can this top hospice provider push higher?
Bet on DuPont Analysis With 5 Top-Ranked Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
Amedisys (AMED) Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Amedisys, Inc. (AMED).
Here's Why You Should Add Amedisys (AMED) to Your Portfolio
by Zacks Equity Research
Amedisys (AMED) continues to see impressive performance by Personal Care business. The company's focus on improving clinical quality buoys optimism.
5 Stocks to Gain as Fed Chair "Blinks" on Rates
by Swarup Gupta
Investors would now best prepare for sunnier days ahead, which make it imperative to pick select growth stocks.
Amedisys (AMED) Up 7.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
What Falling Estimates & Price Mean for DaVita (DVA)
by Zacks Equity Research
DaVita (DVA) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
Why Amedisys (AMED) Could Be an Impressive Growth Stock
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Amedisys (AMED).
Bright Outlook for Outpatient and Home Healthcare Industry
by Zacks Equity Research
Here we discuss how outpatient and home healthcare have been creating opportunities for investors keen on parking their money in this space.
Zacks.com highlights: Robert Half International, Children' Place, Amedisys, Foot Locker and Comfort Systems USA
by Zacks Equity Research
Zacks.com highlights: Robert Half International, Children's Place, Amedisys, Foot Locker and Comfort Systems USA
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
by Zacks Equity Research
Sector ETF report for PSCH
5 Quality Stock Picks Screened on DuPont Analysis
by Sanghamitra Saha
Bet on five top-ranked stocks with higher ROE derived the DuPont way.
5 Low Leverage Stocks You Can Safely Add to Your Portfolio
by Zacks Equity Research
One should keep in mind that debt financing remains a feasible option as long as the companies succeed in generating a higher rate of return compared to the interest rate
Is Amedisys (AMED) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (AMED) Outperforming Other Medical Stocks This Year?